4.7 Article

Improving the Management of COPD in Women

期刊

CHEST
卷 151, 期 3, 页码 686-696

出版社

ELSEVIER
DOI: 10.1016/j.chest.2016.10.031

关键词

COPD; lung function; sex

资金

  1. Novartis Pharma AG, Basel, Switzerland

向作者/读者索取更多资源

COPD is a highly debilitating disease that represents a substantial and growing health burden in women. There is increasing evidence for sex-related differences in COPD risk, progression, and outcomes. However, the disease receives scant attention as a women's health issue. Thus, a multifaceted approach is required to address COPD in women, including greater awareness, minimization of risk, and further elucidation of the sex-specific factors (biological and cultural) that affect risk, disease progression, and treatment success. This article reviews the current literature on the topic and provides suggestions for achieving better outcomes for the millions of women with COPD worldwide.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据